AZ buys Ionis’ NASH candidate
AstraZeneca has bought rights to an experimental antisense therapy from Ionis Pharmaceuticals, in a deal that could be worth more than $300 million - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/az_buys_ionis_nash_candidate_1231077